Research Article
Stability of Positively Charged Nanoemulsion Formulation Containing Steroidal Drug for Effective Transdermal Application
Table 3
Composition and short term stability of formulations from the homogeneous phase.
| | Formulation | Water | PKOEs | Lipoid | Tween 20 | HC | Phenonip | Short term stability |
| | NEA | 48.5% | 20% | 18% | 12% | 1% | 0.5% | ✗ | | NEB | 48.5% | 15% | 21% | 14% | 1% | 0.5% | ✗ | | NEC | 48.5% | 10% | 24% | 16% | 1% | 0.5% | ✓ | | NED | 58.5% | 16% | 14.4% | 9.6% | 1% | 0.5% | ✗ | | NEE | 58.5% | 12% | 16.8% | 11.2% | 1% | 0.5% | ✗ | | NEF | 58.5% | 8% | 19.2% | 12.8% | 1% | 0.5% | ✗ | | NEG | 68.5% | 12% | 10.9% | 7.2% | 1% | 0.5% | ✗ | | NEH | 68.5% | 8% | 13.2% | 8.8% | 1% | 0.5% | ✗ | | NEI | 68.5% | 6% | 14.4% | 9.6% | 1% | 0.5% | ✗ |
|
|
HC: hydrocortisone.
PKOES: palm kernel oil esters.
|
